Literature DB >> 1976143

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

C Coles1, A M Thompson, P A Elder, B B Cohen, I M Mackenzie, G Cranston, U Chetty, J Mackay, M Macdonald, Y Nakamura.   

Abstract

The DNA of paired tumour and blood leucocyte samples from a large series of breast cancer patients was analysed to map regions of loss of heterozygosity on chromosome 17. The high frequency of loss of heterozygosity on 17p was confirmed, and a third of informative tumours had also lost an allele at the long arm locus THH59. On the short arm two distinct regions of loss of heterozygosity were identified, in bands p13-3 and p13-1. The latter probably involves the structural gene p53, which has been implicated as an oncogene or as a tumour suppressor in various human cancers. 17p 13-3, however, showed a significantly higher frequency of loss of heterozygosity, and there was no correlation between allele losses at the two sites. Nevertheless, loss of heterozygosity at 17p 13-3 is associated with overexpression of p53 mRNA, suggesting the existence of a gene some 20 megabases telomeric of p53 that regulates its expression. Lesions of this regulatory gene seem to be involved in the majority of breast cancers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976143     DOI: 10.1016/0140-6736(90)93236-i

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  48 in total

1.  Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.

Authors:  X Cui; H Feiner; Z Lin; H Li
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.

Authors:  P H Cogen; L Daneshvar; A K Metzger; G Duyk; M S Edwards; V C Sheffield
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

3.  Cytogenetic differences in breast cancer samples between German and Japanese patients.

Authors:  J Packeisen; K Nakachi; W Boecker; B Brandt; H Buerger
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  Genetic basis for p53 overexpression in human breast cancer.

Authors:  A M Davidoff; P A Humphrey; J D Iglehart; J R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 5.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

Review 6.  Tumor suppressor genes and medulloblastoma.

Authors:  P H Cogen; J D McDonald
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

7.  Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

Authors:  A L Børresen; E Hovig; B Smith-Sørensen; D Malkin; S Lystad; T I Andersen; J M Nesland; K J Isselbacher; S H Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells.

Authors:  Sanjay Kumar
Journal:  Mol Cell Biochem       Date:  2014-07-04       Impact factor: 3.396

9.  Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.

Authors:  G Sauter; G Deng; H Moch; R Kerschmann; K Matsumura; S De Vries; T George; J Fuentes; P Carroll; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

10.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.

Authors:  J Reifenberger; G Reifenberger; L Liu; C D James; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.